Male Breast Carcinoma Completed Phase 1 Trials for Veliparib (DB07232)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00892736Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyTreatment
NCT01251874Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast CancerTreatment
NCT01145430Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast CancerTreatment
NCT01281150Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsTreatment